Jardiance 25 mg 10 Tablet

Name: Jardiance 25 mg 10 Tablets

description: JARDIANCE contains emplaglifozin. Emplaglyfozin is a reversible inhibitor of sodium-glucose co-transporter 2 (SGLT2), the primary site of reabsorption of filtered glucose in the proximal convoluted tubule of the kidney. This reduces reabsorption of filtered glucose and lowers the renal threshold for glucose, resulting in increased urinary glucose excretion, thereby reducing blood glucose concentrations. Jardiance is used as additional combination therapy with metformin, sulfonylurea and/or pioglitazone in adult patients with type 2 DM to improve glycemic control when diet and exercise alone are inadequate. When using this medication, you must ACCORD TO THE DOCTOR'S INSTRUCTIONS. Purchasing this drug requires education regarding the appropriate and safe use or consumption of the drug which will incur a fee.

composition: Empagliflozin 25 mg

packaging: Box, 3 Blisters @ 10 Film-coated Tablets

how_to_use: Can be consumed with or without food

side_effects: Medication use generally has certain side effects and depends on each individual. If excessive or dangerous side effects occur, please consult medical personnel.
Side effects that may occur when using the drug are: Hypoglycemia, UTI, vaginal moniliasis, vulvovaginitis, balanitis & other genital infections; increased urination, volume depletion. Increase in blood creatinine, hematocrit, serum lipids; decreased glomerular filtration rate. Ketoacidosis, urosepsis, pyelonephritis, allergic skin reactions such as rash, urticaria.

Warning: MUST BE WITH A DOCTOR'S PRESCRIPTION.
Not for patients with type 1 diabetes or those undergoing treatment for diabetic ketoacidosis. Patients on a low carbohydrate diet, acute illness, pancreatic disorders indicating insulin deficiency, reduced insulin dose, alcohol abuse, severe dehydration, history of ketoacidosis. Risk of volume depletion in patients with known CV disease, on antihypertensive therapy with a history of hypotension or in patients ?75 years; Conditions that can cause fluid loss include GI disease. Heart failure (NYHA class I-IV), complicated UTI. Rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption. False positive results on a glucose urine test. Can affect the ability to drive & operate machinery. It is not recommended for use in patients with end-stage renal disease, who are undergoing dialysis. Renal function testing is recommended. Liver damage. Pregnancy & lactation. Children <18 years old. Elderly? 85 years old.

Pregnancy Category:
Category C: May be risky.
Drugs are used with caution if the benefits obtained outweigh the risks to the fetus. Research on animal tests shows risks to the fetus and there has been no direct research on pregnant women.

Prescription information: Prescription needed. Trusted by Bali locals, tourists, expats, and nomads, BaliPharma ensures safety and reliability with convenient delivery across Bali, plus free online doctor consultations at BaliDoc.com for added ease and support.